VVOS NASDAQ
Vivos Therapeutics, Inc.
1W: +7.9%
1M: -12.1%
3M: -68.5%
YTD: -94.0%
1Y: -95.2%
3Y: -96.8%
5Y: -99.9%
$0.15
+0.00 (+1.88%)
Weekly Expected Move ±12.2%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
ESG Scores — VVOS
Company vs Sector Average
Historical ESG Trend
View All ESG Filings (19)
| Date | Form | Environmental | Social | Governance | ESG Score | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | 10-Q | 39.1 | 59.8 | 64.3 | 54.4 | SEC ↗ |
| 2026-03-31 | 10-Q | 40.2 | 66.7 | 68.5 | 58.5 | SEC ↗ |
| 2025-12-31 | 10-K | 60.7 | 64.0 | 61.4 | 62.0 | SEC ↗ |
| 2025-09-30 | 10-Q | 54.2 | 65.7 | 68.5 | 62.8 | SEC ↗ |
| 2025-06-30 | 10-Q | 57.2 | 65.8 | 69.3 | 64.1 | SEC ↗ |
| 2025-03-31 | 10-Q | 55.0 | 76.1 | 71.1 | 67.4 | SEC ↗ |
| 2024-12-31 | 10-K | 61.1 | 64.5 | 60.4 | 62.0 | SEC ↗ |
| 2024-09-30 | 10-Q | 54.2 | 69.0 | 73.7 | 65.6 | SEC ↗ |
| 2024-06-30 | 10-Q | 60.8 | 70.0 | 73.9 | 68.2 | SEC ↗ |
| 2024-03-31 | 10-Q | 60.4 | 69.8 | 75.2 | 68.5 | SEC ↗ |
| 2023-12-31 | 10-K | 60.4 | 63.0 | 61.7 | 61.7 | SEC ↗ |
| 2023-06-30 | 10-Q | 64.0 | 67.6 | 75.8 | 69.1 | SEC ↗ |
| 2023-03-31 | 10-Q | 64.0 | 67.1 | 72.8 | 68.0 | SEC ↗ |
| 2022-12-31 | 10-K | 62.9 | 61.4 | 61.4 | 61.9 | SEC ↗ |
| 2022-06-30 | 10-Q | 65.5 | 66.6 | 77.6 | 69.9 | SEC ↗ |
| 2021-12-31 | 10-K | 61.1 | 59.9 | 62.8 | 61.3 | SEC ↗ |
| 2021-06-30 | 10-Q | 56.0 | 69.7 | 76.2 | 67.3 | SEC ↗ |
| 2021-03-31 | 10-Q | 60.4 | 67.1 | 76.2 | 67.9 | SEC ↗ |
| 2020-12-31 | 10-K | 65.4 | 61.8 | 62.7 | 63.3 | SEC ↗ |